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Graphical abstract 
 
Diazo ester insertion in N-H bonds of amino acid derivatives and insulin 
catalyzed by water-soluble iron and ruthenium porphyrin complexes as 
application of carbenoid transfer in aqueous media 
 
Highlights 
• we report diazo ester insertion in N-H bonds of amino acid derivatives.   
• sulfonated iron porphyrin is an active catalyst for carbenoid insertion in N–H bonds of 
aminoacid derivatives in aqueous media.  
• insertion is regioselective onto the NH2 termini of chain B of insulin. 
 
Abstract 
The metal complex FeTSPPCl (5,10,15,20-tetrakis-(4-sulfonato-phenyl)-porphyrin-iron(III) chloride is 
an active catalyst for carbenoid insertion in N–H bonds of aminoacid derivatives in aqueous media. A 
variety of diazoacetates and methyl diazophosphonate were used as carbenoid precursors. The 
commercially available iron porphyrin complex can also selectively catalyze alkylation of the N-
terminus of insulin (chain B). 
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1. Introduction 
The most common bioconjugations are coupling of a small molecule (such as biotin or a 
fluorescent dye) to a protein. Usual types of bioconjugation chemistry are amine coupling of lysine 
amino acid residues (typically through amine-reactive succinimidyl esters) and sulfhydryl coupling of 
cysteine residues (via a sulfhydryl-reactive maleimide) [1]. Generally, the preparation of bifunctional 
agents involves multistep syntheses, and their subsequent incorporation into biomolecules is often 
hampered by cross-reactivity or nonspecific interactions with other functional groups present. Thus 
the quest for novel, efficient strategies for the synthesis of functional agents, and their incorporation 
into biomolecules, has led to a burgeoning interest in “metallocarbenoid” chemistry [2]. 
The catalytic N-H insertion of α-diazocarbonyl compounds is a powerful organic reaction 
which has various useful applications [3-5].  One of the most successful intramolecular N-H insertions 
has been the conversion of a penicillin analogue into the carbapenem nucleus via rhodium-catalyzed 
insertion of a keto carbenoid into the N-H bond of the β-lactam [6]. More generally, this insertion 
reaction can lead to the synthesis of α-amino esters, dipeptides and nitrogen-containing 
heterocycles. The catalytic preparation of optically active amines, recently reported by Zhou et al.[7] 
is also a nice example of application in asymmetric synthesis. Protein modification through alkylation 
of the N-terminal α-amino acid is also a potentially useful approach such as recently by the group of 
Che [8]. Among the previously reported metal-catalyzed carbenoid transfer, selective tryptophan 
modification with rhodium carbenoids [9, 10] and terminal amino acid modification of proteins with 
ruthenium porphyrins have been  previously explored [11], although in the latter case, a 
stoichiometric amount of the metalloporphyrin was necessary. 
We reported the first success in the use of ruthenium porphyrin catalysts for intermolecular 
insertion of diazo derivatives into N-H bonds in 1997 [12].  Since then, we [13, 14] and others [11,15-
18] have found that ruthenium and iron porphyrins are active catalysts, for carbenoid transfer, not 
only in organic solvents but also in protic solvents and water. Although, there are examples showing 
reactions with diazoacetonitrile [19] diazomethyl phosphonate [20] and trifluoro diazomethane[21] 
in organic solvents, ethyl diazoacetate has been mainly used as the carbenoid precursors in water.  
In this paper, we report NH insertion of amino esters using various diazo esters [5] as 
reagents and the site selective modification of terminal NH2 group of insulin using water-soluble 
5,10,15,20-tetrakis-(4-sulfonato-phenyl)-porphyrin-iron(III) chloride (FeTSPPCl) 1 as catalyst (Scheme 
1). Iron porphyrin-catalyzed NH insertions have been previously studied in organic solvents [15-18]. 
Aviv and Gross [18] also reported intermolecular N-H insertion of anilines in water/THF catalyzed by 
myoglobin. Although, there are many examples showing that 5,10,15,20-tetrakis-(4-sulfonato-
phenyl)-porphyrin-iron(III) chloride is a versatile water-soluble catalyst for oxidations in organic 
syntheses [22] and few other reactions [23,24], its use for carbenoid transfer in water seems to be 
neglected [25]. Comparative evaluation of reactivity for N-H insertion of different diazo derivatives 
with iron and ruthenium porphyrins will also be described.  
 
 
 
 
2. Experimental 
2.1. General 
All reactions were performed under argon and were magnetically stirred. Solvents were 
distilled from appropriate drying agent prior to use: MeOH from turning Mg. Commercially available 
reagents (Acros) were used without further purification unless otherwise stated. All reactions were 
monitored by TLC with Merck pre-coated aluminium foil sheets (Silica gel 60 with fluorescent 
indicator UV254). Compounds were visualized with UV light at 254 nm. Column chromatographies 
were carried out using silica gel from Merck (0.063-0.200 mm). UV-visible spectra were recorded on 
a UVIKON XL from Biotech. MALDI-TOF mass spectra were recorded on microflex Bruker. The analysis 
were performed on a ThermoFisher LC-MS system (a DionexUltiMate 3000 quaternary RSLC Nano-
UPHLC system coupled with a Q-Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer). Ethyl 
diazoacetate and 5,10,15,20-tetrakis-(4-sulfonato-phenyl)-porphyrin-iron(III) chloride are 
commercially available. 5,10,15,20-tetrakis-(4-sulfonato-phenyl)-porphyrin-ruthenium(II) carbonyl 
was prepared as previously reported [14]. Diisopropyl diazomethylphosphonate was prepared as 
previously reported [26,27]. 
2.2 Syntheses of diazo compounds 
The synthesis of substituted benzyl diazoacetates was adapted from the method previously 
reported by Fukuyama [28]. For the synthesis of the 4-(trifluoromethyl)benzyl 2-diazoacetate, 4-
(trifluoromethyl)benzyl bromoacetate was first prepared: 4-(Trifluoromethyl)benzyl alcohol (548 µL, 
4.0 mmol) and NaHCO3 (1.0 g, 12.0 mmol) were dissolved in acetonitrile (20 mL) and 
bromoacetylbromide (524 µL, 6.0 mmol) was added slowly at 0°C in a 100 mL round bottom flask. 
After stirring for 15 min at room temperature, the reaction was quenched with H2O. The solution was 
extracted with CH2Cl2 three times. The organic phase was washed with brine and dried over MgSO4. 
The solvent was evaporated, and the residue was used in the next reaction without purification. The 
4-(trifluoromethyl)benzyl bromoacetate thus obtained and N,N’-ditosylhydrazine (272 mg, 8.0 mmol) 
were dissolved in THF (20 mL) and cooled to 0°C. DBU (3 mL, 20 mmol) was added dropwise and 
stirred at room temperature for 10 minutes. After quenching the reaction by the addition of 
saturated NaHCO3 solution, this was extracted three times with diethylether. The organic phase was 
washed with brine, dried over MgSO4 and evaporated to give the crude diazo acetate. Purification of 
the diazo acetate was performed with neutral silica gel to give 4-(trifluoromethyl)benzyl 2-
diazoacetate as a pale yellow oil (897 mg, 90%, two steps). 
1
H NMR (CDCl3, 400 MHz, ppm): δ 4.83 (s, 
1H, CH=N2), 5.25 (s, 2H, CH2),  7.47 (d, J = 8.02 Hz, 2H),  7.63 (d, J = 7.63 Hz, 2H). 
13
C NMR  (CDCl3, 125 
MHz, ppm): δ 46.48 (CH=N2),  65.56 (CH2), δ 123.05 (CF3),  125.65 (CHPh),  128.23 (CHPh),  130.57 
(Cq-CF3),  140.06 (Cq-CH2),  166.57 (C=O). 
19
F NMR (CDCl3, 400 MHz, ppm): δ -62.67 (s). HR-MS (m/z): 
calculated mass for C10H7N2O2F3Na [M+Na]
+
: 267.03573, found m/z: 267.0356 (0 ppm). 
For the synthesis of the 4-(methylsulfide)benzyl 2-diazoacetate, the previous experimental 
procedure was employed. The expected product was obtained as a yellow oil (yield 88 %).  
1
H NMR 
(CDCl3, 400 MHz, ppm): δ 2.48 (s, 3H, SCH3), 4.79 (s, 1H, CH=N2), 5.16 (s, 2H, CH2), 7.24 – 7.30 (m, 4H, 
Ph). 
13
C NMR (CDCl3, 125 MHz, ppm): δ 15.85 (SCH3), 46.48 (CH=N2), 66.28 (CH2), 126.68 (CHPh),  
129.07 (CHPh),  132.72 (Cq),  139.08 (Cq),  166.8 (CO2). HR-MS (m/z): calculated mass for 
C10H10N2O2NaS [M+Na]+: 245.03607, found m/z: 245.0361 (0 ppm).  
2.3  General procedure for NH insertion in water 
In a typical experiment, the α-amino ester (0.18 mmol) and FeTSPPCl catalyst (1.8 µmol) 
were placed in a schlenck tube under argon and dissolved in 2 ml of degazed bicarbonate buffer 
solution (pH 10). Ethyl diazoacetate (0.18 mmol) was then added at room temperature. After 15 min 
of stirring the reaction was stopped and the mixture was then extracted three times with CH2Cl2, 
dried by MgSO4 and purified by column chromatography on silica gel (CH2Cl2/Methanol:97/3). A 
similar procedure was effective for N-H insertion catalyzed by RuTSPPCO, excepted that the reaction 
was stopped after 4 hours. 
2.4  General procedure for NH insertion in organic solvent 
In a typical experiment the α-amino ester (0.18 mmol) and FeTPPCl (1.3 mg, 1.8 µmol) were 
placed in a schlenck tube under argon and dissolved in 2 ml of distilled CH2Cl2.  NEt3 (0.27 mmol) was 
added to the solution. Ethyl diazoacetate) (0.18 mmol) was then added at room temperature. After 2 
min of stirring, the insertion product was purified by column chromatography on silica gel 
(CH2Cl2/Methanol: 95/5).  
2.5  NH insertion of Insulin 
In a typical experiment, insulin (5 mg, 0.87 µmol) and 0.2 equiv of TPPSFeCl (0.2 mg, 0.17 
µmol) were dissolved in 10 ml of PBS and 5 ml of acetonitrile under nitrogen. 0.32 mg of cobaltocene 
was first added to the solution and then, the diazo derivative (1.3 mmol) diluted in 10 ul of 
acetonitrile. The solution was stirred for 1 hour. The yield was estimated by MALDI-TOF. After 
centrifugation, insulin was purified by preparative HPLC and then dried under vacuum to give a white 
powder. 
2.6 Characterization of N-H inserted compounds 
2.6.1 Reaction of ethyl diazoacetate with amino esters 
Mono-inserted Tyrosine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.23 (t, J = 7.2 Hz, 3 H, CH3), 
2.88-2.98 (m, , 2H, CH2), 3.37 (sys AB, J = 17 Hz, 2 H, CH2), 3.57 (t, 6.8 Hz, 1H, CH), 3.67 (s, 3 H, OCH3), 
4.14 (q, 7 Hz ,2 H, CH2), 6.71 (d, J = 8.5 Hz, 2 H, CH), 7.02 (d, 8.5 Hz, 2 H, CH).
13
C NMR (125 MHz, 
CDCl3, ppm): δ 14.13 (CH3 (CO2Et)), 38.56 (CH2Ph), 49.11 (CH2NH),  51.92 (CH3 (CO2Me)), 61.02 (CH2 
(CO2Et)), 62.23 (*CH), 115.51 (CH, Ph), 128.33 (Cq, CH2Ph), 130.32 (CH, Ph), 154.9 (Cq (PhOH)), 
171.75 (Cq (CO2Et)), 174.22 (Cq (CO2Me)). HR-MS (m/z): calculated mass for C14H19NO5 [M+Na]+ : 
304.29,, found m/z: 304.11(3 ppm) 
Bis-inserted Tyrosine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.25 (t, J = 7.2 Hz, 6H, 2xCH3), δ 
2.91-2.99 (m, 2H, CH2), δ 3.57 (s, 3H, OCH3), 3.63 (t, 6.8 Hz, 1H, CH),  3.71 (s, 4 H, 2xCH2), δ 4.14 (q, 7 
Hz, 2H, CH2), δ 6.71 (d, J = 8.5 Hz, 2H, CH), δ 7.02 (d, 8.5 Hz, 2H, CH). 
13
C NMR (125 MHz, CDCl3, ppm): 
δ 14.32 (CH3 (CO2Et)), δ 36.37 (CH2Ph), δ 51.50 (CH3 (CO2Me)), δ 52.85 (CH2N),  δ 60.82 (CH2 (CO2Et)), 
δ 67.12 (*CH), δ 115.38 (CH, Ph), δ 129.34 (Cq, CH2Ph), δ 130.48 (CH, Ph), δ 154.56 (Cq (PhOH)), δ 
171.60 (Cq (CO2Et)), δ 172.47 (Cq (CO2Me). HR-MS (m/z): calculated mass for C18H25NO7Na [M+Na]
+
: 
390.15287, found m/z: 390.1528 (0 ppm). 
Mono-inserted tryptophan methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.19 (t, J = 7.1 Hz, 6H, 
CH3), 3.12-3,27 (m, 2H, CH2), 3.39 (sys AB, J = 17 Hz, 2H, CH2), 3.66 (s, 3 H, OCH3), 3.70 (t, 6.1 Hz, 1H, 
CH), 4.10 (q, 7.1 Hz, 2H, CH2), 7.08-7.13 (m, 2H, CH), 7.18 (t, J = 7.3 Hz, 1H, CH), 7.34 (d, J = 8 Hz, 1H, 
CH), 7.6 (d, J = 7.8 Hz, 1H, CH), δ 8.19 (s, 1H, NH (indole)). 
13
C NMR (125 MHz, CDCl3, ppm): δ 14.25 
(CH3(CO2Et)), 29.27 (CH2Ph), 49.40 (CH2N),  52.04 (CH3 (CO2Me)), 60.97 (CH2 (CO2Et)), 61.32 (*CH), 
111.03 (Cq), 111.32 (CH), 118.83 (CH), 119.63 (CH), 122.27 (CH), 123.08 (CH), 127.54 (Cq), 136.35 
(Cq),  171.78 (Cq (CO2Et)), 174.52 (Cq (CO2Me)). HR-MS (m/z): calculated mass for C16H20N2O4Na 
[M+Na]
+
: 327.13208; found m/z: 327.1322. 
Bis-inserted tryptophan methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.25 (t, J = 7.1 Hz, 6H, 
2xCH3), δ 3.13-3.28 (m, 2H, CH2), δ 3.57 (s, 3H, OCH3), 3.76 (s, 4H, 2xCH2), 3.82 (t, 7.4 Hz ,1H, CH), δ 
4.14 (q, J = 7 Hz, 2H, CH2), δ 7.11 (t, J = 7.3 Hz, 1H, CH), 7.17 (t, J = 7.2 Hz, 2H, CH), 7.33 (d, J = 8 Hz, 
1H, CH), 7.63(d, J = 7.8 Hz, 1H, CH), δ 7.99 (s, 1H, NH (indole)). 
13
C NMR (125 MHz, CDCl3, ppm): δ 
14.34 (CH3 (CO2Et)), δ 26.58 (CH2Ph), δ 51.45 (CH3 (CO2Me)), δ 52.78 (CH2N),  δ 60.73 (CH2 (CO2Et)), δ 
65.62 (*CH), δ 111.16 (CH), δ 111.45 (Cq), δ 118.79 (CH), δ 119.51 (CH), δ 122.06 (CH), δ 123.15 (CH), 
δ 127.61 (Cq), δ 136.15 (Cq),  δ 171.61 (Cq (CO2Et)), δ 172.76 (Cq (CO2Me). HR-MS (m/z): calculated 
mass for C20H26N2O6Na [M+Na]
+
: 413.16886; found m/z: 413.1701. 
Mono-inserted phenylalanine methyl ester : 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.23 (t, J = 7.2 Hz, 3H, 
CH3), 2.94-3.05 (m, 2H, CH2), 3.36 (sys AB, J = 17 Hz, 2H, CH2NH), 3.60 (t, J = 6.7 Hz ,1H, CH), 3.66 (s, 
3H, CH3), δ 4.14 (q, J = 7.1 Hz, 2H, CH2), δ 7.19-7.30 (m, 5H, Ph). 
13
C NMR (125 MHz, CDCl3, ppm): δ 
14.13 (CH3 (CO2Et)), 39.67 (CH2Ph), 49.32 (CH2NH), 51.85 (CH3 (CO2Me)), 60.99 (CH2 (CO2Et)), 62.31 
(*CH), 127 (CH, Ph), 128.65 (CH, Ph), 129.32 (CH, Ph), 137.04 (Cq (PhCH2)), 171.72 (Cq (CO2Et)), 
174.21 (Cq (CO2Me). HR-MS (m/z): calculated mass for C14H19NO5Na [M+Na]
+
: 288,12118; found m/z: 
288,1207 (2 ppm). 
Bis-inserted phenylalanine methyl ester : 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.25 (t, J = 7.1 Hz, 6H, 
2xCH3), 2.99-3.08 (m, 2H, CH2), 3.57 (s, 3H, CH3), 3.66-3.70 (m, 1H, CH), 3.72 (s, 4H, 2xCH2), 4.14 (q, J 
= 7.1 Hz, 4H, 2xCH2), 7.17-7.27 (m, 5H, Ph). 
13
C NMR (125 MHz, CDCl3, ppm): δ 14.34 (CH3 (CO2Et)), 
37.28 (CH2Ph), 52.87 (CH2NH), 51.46 (CH3 (CO2Me)), 60.75 (CH2 (CO2Et)), 66.9 (*CH), 126.69 (CH, Ph), 
128.50 (CH, Ph), 129.37 (CH, Ph), 137.50 (Cq (PhCH2)), 171.48 (Cq (CO2Et)), 172.26 (Cq (CO2Me)). HR-
MS (m/z): calculated mass for C18H25NO6Na [M+Na]
+
: 374.15796; found m/z: 374.1590 (3 ppm). 
Mono-inserted glycine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.25 (t, J = 7.13 Hz, 3H, CH3 
(CO2Et), 3.44 (s, 2H, CH2), 3.46 (s, 2H, CH2 (CH2NH)),  3.71 (s, 3H, CH3 (CO2Me)), 4.17 (q, J = 7.17 Hz, 
2H, CH2 (CO2Et)).    
13
C NMR (125 MHz, CDCl3, ppm): δ 14.27 (CH3 (CO2Et)), 50.05 (CH2), 50.23 (CH2), 
51.93 (CH3), 60.95 (CH2 (CO2Et)), 171.83 (Cq (CO2Et)), 172.30 (Cq (CO2Me)). HR-MS (m/z): calculated 
mass for C7H13NO4Na [M+Na]
+
: 198,07423; found m/z: 198,0748 (3 ppm). 
Bis-inserted glycine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.24 (t, J = 7.2 Hz, 3H, CH3 
(CO2Et), 3.63 (s, 4H, CH2(NHCH2)), 3.65 (s, 2H, CH2(CH2NH)), 3.69 (s, 3H, CH3(CO2Me)), 4.15 (q, J = 7.2 
Hz, 2H, CH2(CO2Et)).    
13
C NMR (125 MHz, CDCl3, ppm): δ 14.31 (CH3 (CO2Et)), 51.81 (CH3 (CO2Me)), 
55.10 (CH2 (CH2CO2Me)), 55.29 (NHCH2), 60.80 (CH2 (CO2Et)), 170.87 (Cq (CO2Et)), 171.37 (Cq 
(CO2Me)). HR-MS (m/z): calculated mass for C11H19NO6Na [M+Na]
+
: 284.11101; found m/z: 284.11111 
(0 ppm). 
Mono-inserted lysine methyl ester: 
1
H NMR (500MHz, CDCl3, ppm): δ 1.23 (t, 3H, CH3), 1.45 (m, 4H, 
2xCH2), 1.65 (m, 2H, CH2), 2.69 (t, 2H, CH2), 3.36 (sys AB, 17.0 Hz, 2H, CH2NH), 3.71 (s, 3H, CH3), 4.15 
(q, 2H, CH2), 4.17 (m, 1H, CH). 
Mono-inserted S-H cysteine ethyl ester: 
1
H NMR (400MHz, CDCl3, ppm): δ 1.32 (2t, 6H, CH3), 2.97-
3.13 (m, 2H, CH2C*), 3.26 (s, 2H, CH2S), 3.79 (m, 1H, C*H), 4.24 (2m, 4H, CH2) containing also 20% of 
N-H inserted cysteine. 
2.6.2 Reaction of 4-(trifluoromethyl)benzyl 2-diazoacetate with amino esters 
Mono-inserted phenylalanine methyl ester: 
1
H NMR  (500MHz, CDCl3, ppm): δ 2.93–3.05 (m, 2H, 
CH2), 3.42 (sys AB, J = 17.40 Hz, 2H, CH2NH), 3.61 (t, J = 6.90 Hz, 1H, *CH), 3.65 (s, 3H, OCH3), 5.16 (s, 
2H, OCH2), 7.17–7.29 (m, 4H, Ph), 7.42 (d, J = 8 Hz, 2H, Ph), 7.60 (d, J = 8 Hz, 2H, Ph). 
13
C NMR (125 
MHz, CDCl3, ppm): δ 39.67 (CH2), 49.27 (CH2), δ 51.99 (CH3O), 62.23 (*CH), 65.71 (CH2), 124.09 (q, 
1
JCF = 272.14 Hz, CF3), 125.68 (q, 
3
JCF = 3,78 Hz, Ph), 127.04 (Ph), 128.40 (Ph), 128.66 (Ph), 129.31 
(Ph), 130.66 (q, 
2
JCF = 32.57 Hz, Cq), 136.95 (Cq), 139.59 (Cq), 171.45 (Cq, CO2CH2), 174.13 (Cq, 
CO2Me). NMR 
19
F (CDCl3, 376 MHz, ppm): δ -62.685.HR-MS (m/z): calculated mass for C20H20NO4F3Na 
[M+Na]
+
: 418,12421; found m/z: 418,1239 (1 ppm). 
Mono-inserted tryptophan methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 2.07 (s, 1H, NH), δ 3.12–
3.28 (m, 2H, CH2), 3.48 (sys AB, J = 17.38 Hz, 2H, CH2-NH), 3.66 (s, 3H, CH3), 3.72 (t, J = 7.08 Hz, 1H, 
CH), 5.12 (sys AB, J = 6.82 Hz, 2H, CH2Ph), 7.07 (d, J = 1.99 Hz, 1H, Hindole), 7.13 (t, J = 7.75 Hz, 1H, 
Hindole), 7.2 (t, J = 7.69 Hz, 1H, Hindole),  7.34 (d, J = 8.11 Hz, 1H, Hindole), 7.38 (d, J = 8.01 Hz, 2H, 
Ph), 7.59 (d, J = 7.97 MHz, 2H, Ph), 7.60 (d, J = 7.04 Hz, 1H, Hindole), δ 8.12 (s, 1H, NHindole). 
13
C 
NMR (125 MHz, CDCl3, ppm): δ 29.27 (CH2), 49.34 (CH2), 52.05 (OCH3), 61.26 (*CH), 65.63 (CH2), 
110.86 (Cq), 111.37 (CHNH), 118.75 (Ph), 119.59 (Ph), 122.24 (Ph), 123.15 (Ph), 124.08 (q, 1JCF = 
272.04 Hz, CF3), 125.61 (q, 
3
JCF = 3.74 Hz, CH), 127.47 (Cq), δ 128.33 (Ph), 130.54 (q, 2JCF = 32.42, Cq), 
136.36 (Cq), 139.57 (Cq), 171.54 (Cq, CO2CH2), 174.48 (Cq, CO2Me). 
19
F NMR (CDCl3, 376 MHz, ppm): 
δ -62.632. HR-MS (m/z): calculated mass for C22H21N2O4F3Na [M+Na]
+
: 457.1351; found m/z: 457.135 
(0 ppm). 
Mono-inserted tyrosine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 2.87–2.96 (m, 2H, CH2), 3.46 
(sys AB, J = 17.4 Hz, 2H, CH2NH),  3.59 (t, J = 6.60 Hz, 1H, CH), 3.67 (s, 3H, CH3), δ 5.16 (s, 2H, 
CH2OCO), 6.69 (d, J = 8.44, Hz, 2H, PhOH), 7.0 (d, J = 8.44 Hz, 2H PhOH), ), 7.4 (d, J = 8.03 Hz, 2H 
PhCF3), 7.6 (d, J = 8.1 Hz, 2H PhCF3).
13
C NMR (125 MHz, CDCl3, ppm): δ 38.59 (CH2), 49.11 (CH2), 52.1 
(CH3O), 62.23 (*CH), 65.84 (CH2), 115.68 (Ph), 124.05 (q, 
1
JCF = 272.08 Hz, CF3), 125.65 (q, 
3
JCF = 3.71 
Hz, CH), 128.12 (Cq), 128.37 (Ph), 130.40 (Ph), 130.45 (q, 
2
JCF = 32.51 Hz, Cq), 139.42 (Cq), 155.15 
(Cq), 171.56 (Cq, CO2CH2), 174.32 (Cq, CO2Me). 
19
F NMR (CDCl3, 376 MHz, ppm): δ -62.668. HR-MS 
(m/z): calculated mass for C20H20NO5F3Na [M+Na]
+
: 434.11913; found m/z: 434.1187 (1 ppm). 
Mono-inserted phenylalanine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 4.00 (s, 2H, CH2, 
(NHCH2) ), δ 5.26 (s, 2H, CH2),  6.62 (d, J = 7.71 Hz, 2H, o-Ph ), δ 6.77 (t, J = 7.34 Hz, 1H, p-Ph), 7.20 (t, 
2H,  J = 7.44 Hz, m-Ph),  7.42 (d, J = 8.01 Hz, 2H, Ph),  7.62 (d, J = 8.01 Hz, 2H, Ph). 
13
C NMR (125 MHz, 
CDCl3, ppm): δ 46.02 (CH2), 66.10 (CH2), 113.19 (CH), 118.70 (CH), 124.07 (q, 
1
JCF = 272.17 Hz, CF3), 
125.72 (q, 
2
JCF = 3.72 Hz, CH), 128.41 (Ph), 129.50 (Ph), 130.73 (q, 
2
JCF = 32.53 Hz, Cq), 139.41 (Cq), 
146.99 (Cq), 171.12 (Cq, CO2CH2). NMR 
19
F (CDCl3, 376 MHz, ppm): δ -62.682. HR-MS (m/z): 
calculated mass for C16H14NO2F3Na [M+Na]
+
: 332.08743; found m/z: 332.0873 (0 ppm). 
2.6.3 Reaction of 4-(methylsulfide)benzyl 2-diazoacetate with amino acid derivatives  
Mono-inserted aniline: 
1
H NMR (500 MHz, CDCl3, ppm): δ 2.38 (s, 3H, (SCH3)), 3.83 (s, 2H, (CH2) 
NHCH2 ), 5.06 (s, 2H, CH2Ph), 6.50 (d, J = 7.69 Hz, 2H,o-Ph ), 6.65 (t, J = 7.34 Hz, 1H, p-Ph), 7.08 (t, 2H,  
J = 7.42 Hz, o-Ph), 7.15 (sys AB, J = 8.65 Hz, 4H, Ph). 
13
C NMR (125 MHz, CDCl3, ppm): δ 15.71 (SCH3), 
45.98 (CH2), 66.76 (CH2), 113.11 (CH),  118.37 (CH),  126.57 (CH),  129.16 (CH),  129.40 (CH),  132.05 
(Cq),  139.31 (Cq),  147.03 (Cq),  171.15 (Cq). HR-MS (m/z): calculated mass for C16H17NO2NaS 
[M+Na]
+
: 310.08777; found m/z: 310.0879 (0 ppm). 
Mono-inserted phenylalanine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 2.01 (s, 1H, NH), 2.5 (s, 
3H, CH3S), 2.96–3.08 (m, 2H, CH2), 3.43 (sys AB, J = 16.34 Hz, 2H, CH2NH), 3.64 (t, J = 6.81 Hz, 1H, CH), 
3.67 (s, 3H, CH3O), 5.1 (s, 2H, CH2O), 7.2–7.31 (m, 9H, Ph). 
13
C NMR (125 MHz, CDCl3, ppm): δ 15.78 
(CH3S), 39.57 (CH2), 49.24 (CH2), 51.89 (CH3O), 62.17 (*CH), 66.32 (CH2), 123.90 (Ph), 126.60 (Ph), 
126.94 (Ph), 128.58 (Ph), 129.120 (Ph), 129.26 (Ph), 132.26 (Cq), 136.94 (Cq), 139.13 (Cq), 171.52 (Cq, 
CO2CH2), 174.08 (Cq, CO2Me). HR-MS (m/z): calculated mass for C20H23NO4NaS [M+Na]
+
: [M+Na]+: 
396.12455; found m/z: 396.1248 (1 ppm). 
Mono-inserted tryptophan methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.93 (s, 1H, NH), 2.47 (s, 
3H, CH3S), 3.15–3,27 (m, 2H, CH2), 3.44 (sys AB, J = 16.35 Hz, 2H, CH2NH), 3.64 (s, 3H, CH3O), 3.69 (t, J 
= 6.08 Hz, 1H, CH), 5.03 (sys AB, J = 5.12 Hz, 2H, CH2Ph), 7.09 (d, J = 2.02 Hz, 1H, Hindole), 7.12 (t, J = 
7.78 Hz, 1H, Hindole), 7.18 (t, J = 7.29 Hz, 1H, Hindole), 7.35 (d, J = 8.03 Hz, 1H, Hindole), 7.6 (d, J = 
7.84 Hz, 1H, Hindole), 8.07 (s, 1H, NHindole). 
13
C NMR (125 MHz, CDCl3, ppm): δ 15.73 (CH3S), 29.21 
(CH2), 49.35 (CH2), 52.0 (CH3O), 61.23 (*CH),  66.29 (CH2), 110.71 (Cq), 111.35 (CH), 118.69 (CH), 
119.48 (CH), 122.11 (CH), 123.19 (CH), 126.53 (CH), 127.43 (Cq), 129.1 (CH), 132.23 (Cq), 136.3 (Cq), 
139.06 (Cq), 171.66 (Cq, COOCH2), 174.48 (Cq, CO2Me). HR-MS (m/z): calculated mass for 
C22H24N2O4NaS [M+Na]
+
: 435.13545; found m/z: 435.1357 (1 ppm). 
Mono-inserted tyrosine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 2.51 (s, 3H, CH3S), 2.9–3.02 
(m, 2H, CH2), 3.45 (AB sys, J = 16.48 Hz, 2H, CH2NH), 3.61 (t, J = 6.72 Hz, 1H, CH), 3.7 (s, 3H, CH3O), 
5.10 (s, 2H, CH2),  6.72 (d, J = 8.37 Hz, 2H, PhOH), δ  7.04 (d, J = 8.33 Hz, 2H, PhOH), δ  7.24–7.28 (m, 
4H, PhSMe). 
13
C NMR (125 MHz, CDCl3, ppm): δ 15.73 (CH3S), 38.59 (CH2), 49.17 (CH2), 52.05 (CH3O), 
62.24 (C*H), 66.51 (CH2), 115.65 (Ph), 126.57 (Ph), 128.13 (Cq), 129.14 (Ph), 130.37 (Ph), 132.1 (Cq), 
139.14 (Cq), δ 155.13 (Cq), 171.68 (Cq, CO2CH2), 174.3 (Cq, COOMe). HR-MS (m/z): calculated mass 
for C20H23NO5NaS [M+Na]
+
: [412.11946; found m/z: 412.1195 (0 ppm). 
2.6.4 Reaction of diisopropyl diazomethylphosphonate with amino acid derivatives  
Mono-inserted aniline: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.32 (d, J = 6.2 Hz, 6H, 2xCH3), 1.37 (d, J = 
6.2 Hz, 6H, 2xCH3), 3.46 (d, JHP = 13.7 Hz, 2H, CH2), 3.96 (s broad, 1H, NH),  4.73-4.82 (m, JHH  = JHP = 
6.3 Hz, 2H, CHOP), 6.68 (d, J = 7.8 Hz, 2H, Ph), 6.77  (t, J = 7.3 Hz, 1H, Ph), 7.21 (t, J = 7.5 Hz, 2H, Ph). 
13
C NMR, HMBC (125MHz, CDCl3, ppm): δ 23.94 (d, 
3
JCP = 4.7 Hz, 2xCH3), 24.06 (d, 
3
JCP = 3.8 Hz, 
2xCH3), 41.03 (d, 
1
JCP = 156.13 Hz, NHCH2), 71.18 (d, 
2
JCP  = 6.72 Hz, 2xCHOP), 113.26 (o-Ph), 118.37 (p-
Ph), 129.19 (m-Ph), 147.67 (d, 
3
JCP = 3.8 Hz, Cq). 
31
P NMR (162 MHz, CDCl3, ppm): δ 22.68 (s). HRMS 
(m/z): calculated mass for C13H22NO3NaP (M+Na)
+
: 294.1235; found m/z: 294.1236 (0 ppm). 
Mono-inserted tryptophan methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.22 (t, J = 6.44 Hz, 6H, 
2xCH3), δ 1.26 (t, J = 6.59 Hz, 6H, 2xCH3), δ 2.79 (t, J = 14.37 Hz, 1H, CH2), 3.04 (t, J = 12.94 Hz, 1H, 
CH2), 3.08-3.21 (m, 2H, CH2 (tryp)), 3.63 (s, 3H, CH3 (OCH3)), 3.73  (t, J = 6.39 Hz, 1H, *CH), 4.6-4.7 (m, 
JHH = JHP = 6.3 Hz, 2H, CHOP), 6.99 (s, 1H, Hindole), 7.08 (t, 1H, 7.38 Hz, Ph), 7.15 (t, 1H, J = 7.76 Hz, 
Ph), 7.33 (d, 1H, J = 8.1 Hz, Ph), 7.57 (d, 1H, 7.88 Hz, Ph).
13
C NMR (125 MHz, CDCl3, ppm): δ 23.96 (2d, 
J = 5.09, 5.78 Hz, 2xCH3), 24.12 (d, J = 3.74 Hz, 2xCH3),  29.13 (CH2, (tryp)), 44.47 (d, 
1
JCP = 158.17 Hz, 
NHCH2), 51.86 (OCH3), 62.82 (d, 
3
JCP = 15.44 Hz, *CH), 70.78 (d, 
2
J = 1.8 Hz, CH), 70.94 (s, CH), 110.68 
(Cq indole), 111.38 (CH indole), 118.71 (CH indole), 119.35 (CH indole), 121.95 (CH indole), 123.20 
(CH indole), 127.54 (Cq indole), 136.39 (Cq indole), 174.55 (Cq (CO)).
31
P NMR  (162MHz, CDCl3, ppm): 
δ 23.13 (s). HR-MS (m/z): calculated mass for (C19H29N2O5NaP) [M+Na]
+
: 419.1711; found: 419.1712 
(0 ppm). 
Mono-inserted tyrosine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.22 (t, J = 5.81 Hz, 6H, CH3),  
1.26 (d, J = 6.18 Hz, 6H, CH3), 2.74 (t, J = 14.38 Hz, 1H, CH2), 2.77-2.93 (m, 2H, CH2 (tyrosine)),  3.01 (t, 
J = 11.85 Hz, 1H, CH2), 3.59 (t, J = 6.58 Hz, 1H, *CH), 3.65 (s, 3H, OCH3),  4.58-4.69 (m, JHP  = JCP = 6.01 
Hz, 2H, CHOP),  6.74 (d, 2H, 8.33 Hz, Ph), 6.96 (d, 1H, 8.33 Hz, CH (Ph). 
13
C NMR (125 MHz, CDCl3, 
ppm): δ 23.96 (2d, 
3
JCP = 4.86 Hz, 2xCH3), δ 24.1 (d, 
3
JCP = 3.63 Hz, CH3), 38.67 (CH2 (tyrosine)),  44.32 
(d, 
1
JCP = 160.04 Hz, NHCH2),  51.86 (OCH3)), 63.71 (d, 
3
JCP = 14.96 Hz, *CH),  71.42 (2d, 
2
JCP = 6.84 Hz, 
CH) 115.58 (Ph),  127.54 (Cq, Ph), 130.24 (Ph), 156.1 (Cq), 174.41 (Cq (CO2Me)). 
31
P NMR (162 MHz, 
CDCl3, ppm): δ 22.93 (s). HR-MS (m/z): calculated mass for (C17H28NO6NaP) [M+Na]
+
: 396.1552; 
found: 396.1553 (0 ppm). 
Mono-inserted phenylalanine methyl ester: 
1
H NMR (500 MHz, CDCl3, ppm): δ 1.24 (t, J = 7.16 Hz, 6H, 
2xCH3), 1.27-1.29 (m, 6H, 2xCH3), 1.71 (s large, 1H, NH), 2.76 (t, 1H, CH2 (NHCH2)), 2.89-3.02 (m, CH2 
(Phenylala.) + 1 CH2 (NHCH2)), 3.64 (t, 6.77 Hz, 1H, *CH), 3.67 (s, 3H, (OCH3)), 4.61-4.70 (m, 2H, CH, 
7.17-7.28 (m, 5H, Ph)). 
13
C NMR (125 MHz, CDCl3, ppm): δ 24.06 (2d, 
3
JCP = 4.9 Hz, 2xCH3(isopropyl)), 
24.2 (2d, 
3
JCP = 2.57 Hz, 2xCH3), 39.56 (CH2 (phenylala.)),  45.29 (CH2, NHCH2), 51.88 (OCH3)), 63.66 (d, 
3
JCP = 15.42 Hz, *CH), 70.91 (2d, 
2
JCP = 6.52, 6.93Hz, 2xCH, 126.88 (Ph), 128.56 (Ph), 129.36 (Ph), 
137.23 (Cq), 174.28 (Cq (CO2Me)). NMR 
31
P (162 MHz, CDCl3, ppm): 22.73 (s). HR-MS (m/z): 
calculated mass for C17H28NO5PNa [M+Na]
+
: 380.16028; found m/z: 380.1598 (1 ppm). 
3. Results and discussion 
3.1 Synthesis of diazo derivatives 
Besides ethyl diazoacetate and diisopropyl diazomethylphosphonate, two substituted benzyl 
diazo acetates were also investigated in order to introduce SMe and trifluoromethyl groups. A tosyl 
group was employed for the synthesis due the availability of inexpensive p-toluenesulfonyl 
hydrazide. The first step was the preparation of 4-(trifluoromethyl)benzylbromoacetate and 4-
(methylsulfide)benzylbromoacetate from 4-(trifluoromethyl)benzyl alcohol and 4-
(methylsulfide)benzyl alcohol, respectively. Finally, these bromoacetates underwent an easy 
conversion to the corresponding diazo acetates upon treatment with N,N’-ditosylhydrazine and DBU 
at 0°C, following the protocol previously reported by Fukuyama[28]. The preparation of 4-
(trifluoromethyl)benzyl 2-diazoacetate proceeded in a 90% yield, while that of 4-
(methylsulfide)benzyl 2-diazoacetate in  88% yield. These diazoacetates were characterized by 
1
H and 
the latter by 
19
F NMR spectroscopy. We note the presence of a characteristic peak at 4.83 ppm and 
4.79 ppm (broad singlet) corresponding to CH neighboring N2 for the CF3 and SCH3 derivatives, 
respectively. 
3.2 NH insertion of amino acid esters by ethyl diazoacetate in water. 
The insertion of electrophilic carbenes into the N-H bonds of α-amino acids and α-amino acid 
esters could be a powerful method for N-alkylating this important class of compounds. However 
there are several drawbacks and the regioselectivity of the reaction still appears as a difficult 
problem to solve. This is due to numerous possible reactive sites such as acidic groups, amino groups, 
thiol groups and phenol groups. To shine some light on this aspect, we first investigated the 
regioselectivity of the reaction catalyzed by 5,10,15,20-tetrakis-(4-sulfonato-phenyl)-porphyrin-
iron(III) chloride (FeTSPPCl) (Figure 1) in water.  
The results are summarized in Table 1. Thus FeTSPPCl catalyzed decomposition of 1 equiv of 
ethyl diazoacetate in the presence of tyrosine methyl ester in dichloromethane resulted in the 
formation of mono N-alkylated amino esters in 71% yield, containing 14% of bis-inserted compound 
(Table 1, entry 4). A similar result was obtained for tryptophan with 66% yield (Table 1, entry 3). In 
this case 18% of insertion was the bis-inserted compound (Scheme 2). To extend the scope of this N-
H insertion, the reaction of a number of amino acid derivatives with ethyl diazoacetate in the 
presence of TSPPFeCl as catalyst was studied at room temperature (25°C). In all these experiments, 
N-H insertion is the major reaction yielding alkylated products with moderate yield (43-71%), usually 
obtained with a small amount of bis-inserted compounds. Glycine is an exception since, in this case, 
the bis-inserted compounds was obtained with 32% yield (Table 1, entry 6). A complete 
regioselectivity is obtained with tyrosine, since no O-H insertion was detected. With tryptophan 
methyl ester, only α−amino group was reactive since no insertion was detected in the NH group of 
indole ring. Because the difference of pKa values of the N-terminal group (~7.6-8) and the NH2 group 
in the side chain of lysine residue (10.0-10.2), this reaction  (81% yield) can also be optimized to 
maximize the selectivity for the N-terminal insertion by the reaction being performed under weakly 
basic conditions (pH 9). Actually cysteine ethyl ester was also tested to detect any selectively. With 
this amino ester, both N-H insertion and S-H insertion were observed, the latter being largely 
predominant (> 70%, from 
1
H NMR) using one equivalent of the diazo derivative. Unfortunately, we 
were not able to separate the two compounds. 
The diazo acetates were added to the amino acids in a water-methanol solution containing 
the catalyst under argon. Argon was used as a protecting atmosphere due to a possible formation of 
reduced iron (II) in the catalytic cycle [17]. The reactions were followed by TLC and were left until the 
complete disappearance of the diazo acetates. We note that traces of the amino acids remained 
when the reactions were over and this is due to the formation of carbene dimers. The products were 
characterized by NMR spectroscopy. We note in the 
1
H NMR spectrum, the presence of characteristic 
AB systems (~ 3.4 ppm), which are due to the two protons on the carbon next to the amine function. 
For example, the spectrum resulting after diazo insertion in tryptophan is shown Figure 2. This result 
was observed for all chiral amino esters and is related to the presence of the asymmetric carbon 
atom. With glycine, only one singlet was noted at 3.6 ppm. 
Although there are a large range of strategies and reagents for coupling amino acids 
available, racemization of amino acids is still a major problem in these reactions [29]. Due to the 
basic pH of the carbonate buffer solution, it was necessary to verify the absence of racemization 
during the insertion process [29, 30]. Phenylalanine methyl ester was used as substrate to check a 
possible racemization. After ethyl diazoacetate coupling, the enantiomeric and the racemic forms of 
phenylalanine were analyzed separately on HPLC column with chiral phase as the stationary phase. 
The results are summarized in Figure 3. The chiral analysis gave 50% of each isomer after insertion 
with racemic phenylalanine whereas a pure enantiomer was obtained with L-phenylalanine, as 
expected for a reaction without any racemization. 
3.3 NH insertion of amino acid esters by benzyl diazocetate derivatives 
We first investigated the reaction of 4-(thiomethyl)benzyl diazoacetate and 4-
(trifluoromethyl)benzyl diazoacetate with aniline and amino esters (Table 2) in organic solvent. In 
particular, we wanted to check if these reactions can tolerate the presence of sulfur atom in the 
diazo compound. The insertion reactions are shown in Scheme 3 and the results reported in Table 2. 
In these case, the catalyst used for these reaction was TPPFeCl  (Figure 1). The reactions are very fast 
(< 2 mn). The yields obtained are quite high (87-88%) with the diazoester bearing the CF3 groups if 
we except the results obtained with tyrosine (66%)(Table 2, entry 4) due probably to solubility 
difficulty in CH2Cl2. Aniline gave also a good yield (97%) (Table 2, entry 1). In contrast, the yields are 
only moderate with the diazo bearing the SMe group (50-67%) and some amount of the starting 
material was recovered (Table 2, entries 5-8). A possible interaction of the sulfur atom with iron may 
inhibit the catalyst, and consequently may explain the low conversion. As previously indicated with 
ethyl diazoacetate, all the insertion products were characterized by NMR, showing also an AB system 
for CH2 group in alpha position of the nitrogen.  
To examine whether these diazo derivatives could be used for intermolecular N-H insertion 
of amino acid derivatives in protein, the catalytic reaction was also realized with water soluble tetra-
p-(SO3-)phenyl metalloporphyrins (Fe and Ru).  These two metalloporphyrins were chosen because 
they are easily prepared and commercially available. With the goal of developing protein-compatible 
reaction conditions, we selected methanol as a co-solvent for diazo ester and amino acid derivative 
solubilities. All the reactions with benzyl diazoacetate derivatives are summarized in Table 3. First, it 
should be noted that the yields are only moderare (40-60%) using a small excess of the diazo 
derivatives (2 equiv) vs substrate. In these water conditions, insertion of the α-amino group was only 
observed with lysine methyl ester. As both ruthenium and iron porphyrins react with nitrogen 
compounds to form stable adducts, their decreased activity (by comparison with cyclopropanation 
reactions)[31] can be attributed to competitive coordination between the amino substrate and ethyl 
diazoacetate onto the metal. Since axial Ru-N bond seems much stronger than Fe-N bond, iron 
catalysts are more efficient but less tolerant to functional group such as thiol groups. 
In order to give a clearer characterization of the products, a HMBC spectrum was done for 
the NH insertion reaction of tyrosine with 4-(methylsulfide)benzyl 2-diazoacetate (Figure 3). This 
spectrum shows the coupling between a carbon and hydrogen present on the neighboring carbon. 
We note a coupling between the protons of CH2 (CH2NH) and the asymmetric carbon of the amino 
acid. Also, these protons are coupled to the carbon of the ester function. This result proves the 
formation of the NH-CH2 bond. 
 
 
 
3.4 NH insertion of amino acid esters by diisopropyl diazomethylphosphonate  
Intramolecular N-H insertion of diazomethylphosphonate derivatives was first developed for 
the synthesis of antibiotic carbapenems [32]. Since then Moody et al [33] have developed significant 
diazomethylphosphonate-insertion reactions using rhodium complexes as catalysts for a carbenoid 
approach to peptide synthesis [34]. Many other biological applications have been related to the use 
of N-(phophomethyl) aminoacids such as shikimate pathway inhibitors [35] and selective thrombin 
inhibitors [36]. 
We previously reported the catalytic effectiveness of ruthenium porphyrins for carbenoid 
generation in reactions of diisopropyl diazomethylphosphonate with alkenes (cyclopropanation) [37] 
and allylic amine (N-H insertion) [38]. We herein report the N-H insertion of diazophosphonate into 
amino acid derivatives catalyzed by FeTSPPCl. The results are summarized in Table 4.  In a typical 
reaction, catalytic insertions into N-H bonds were run in in water/methanol solution at room 
temperature under argon atmosphere with a substrate:diazo:catalyst ratio of 100:100:1. As shown in 
Table 4, the coupling products are formed with good yield 81-96% both for aniline and amino acid 
derivatives without detection of dimerization. Again, no OH insertion was detected for tyrosine. 
3.5  NH insertion of insulin by diazo derivatives in water-acetonitrile mixture  
Insulin is a polypeptide hormone that is critical for the metabolism of glucose. The insulin 
monomer consists of two chains, a 21-residue A chain and a 30-residue B chain, linked by a pair of 
disulfide bonds, A7-B7 and A20-B-19; an additional intrachain disulfide bond links A6 and A11. While 
insulin is synthesized and stored in the pancreas as a hexamer, the hormonally active form is the 
monomer. Because the hormone contains many functional different groups, it is a good candidate to 
test our catalytic system for bioconjugation. 
Coupling was first attempted in the pH range 7.4 using ethyl diazoacetate and TSPPFeCl as 
catalyst. Cobaltocene was used in the insertion of insulin to reduce iron(III) to iron(II). In the previous 
experiments, ligation of the amino group of the amino acid derivatives to iron is supposed to 
facilitate the reaction [17]. This is unlikely with insulin. In these experimental conditions, reaction of 
ethyl diazoacetate with insulin in PBS/acetonitrile (7/4) at 25°c for 1h afforded the coupling product 
with 90% insulin conversion containing 10% of double insertion (see Figure 4 and Table 5). 
Purification was carried out by dialysis to remove reagents of molecular weight <3000 Da followed by 
HPLC chromatography to remove residual unconjugated insulin. 
Analysis by MALDI-TOF MS upon purification by HPLC, revealed a peak at 5734 + 86 = 5820 
(MH+), consistent with the incorporation of one acetate carbene unit. Electrospray MS/MS (see 
experimental section and Figure 5) of this mono-ligated species as compared to unmodified insulin, 
revealed attachment of the ester moiety to the FVNQHL peptide only, corresponding to the N termini 
of chain B. Fragmentation of this peptide yielded peaks at m/z = 206 (ion a1), m/z = 305 (ion a2), m/z 
= 333 (ion b2), m/z = 447 (ion b3),  m/z = 676 (ion b4) and m/z = 712 (ion b5), according to the 
modification of the phenylalanine in N-termini. In contrast, fragmentation of chain A, revealed two 
unmodified peptides, one from the N-termini (GIVEQ) and the second to the acid termini 
(GERGFFYTPKA). This result showed that neither N termini nor the NH2 of lysine was tethered by the 
ester group of the diazo precursor. 
In order to confirm this result, 
1
H NMR analysis of modified insulin revealed an AB spectrum 
for the CH2 group, in alpha position of NH, located at 3.4 ppm as expected for a chiral amino acid. In 
contrast the CH2 group ligated to Gly, revealed a singlet according to the results obtained with the 
amino ester models. Moreover, the methyl group, of the ligated acetate can also be detected in the 
NMR spectrum (Figure 6).  
 Other diazo derivatives were also tested for coupling to insulin (see Table 5). Whereas 4-
(methylsulfide)benzyl 2-diazoacetate failed to give any adduct, the coupling of 4-
(trifluoromethyl)benzyl diazoacetate to insulin was quite successful with 75% conversion and a very 
small amount of bis-insertion (2%) as detected by MALDI (see Figure 4B). A stoichiometric amount of 
TSPPFeCl was necessary to give 20% conversion with diisopropyl diazomethylphosphonate. 
Conclusion 
This paper suggests that diazo chemistry is not the perfect conjugation and assembly 
technology for all applications, but provides a powerful, attractive alternative to conventional 
chemistry. As a method for applying metal-catalyzed carbenoid transfer reactions for selective 
modification of proteins, various amino esters were used as models for NH insertion reactions by 
four different diazo acetates using hydrosoluble porphyrin complex, TSPPFeCl. We conclude the 
absence of any O-H insertion, neither from methanol nor from water. It also shows a total 
regioselectivity (tryptophan and tyrosine). As observed with insulin, insertion is regioselective onto 
the NH2 termini. In contrast, no regioselectivity was noted with cysteine. The introduction of new 
functional groups on specific sites containing NH groups can modify the stability of the 
macromolecules, their biological activity and the interactions between them. In the future, the 
challenge is to optimize all the possible parameters in water and in protic solvents using diazo ester 
compounds having functions adapted to the desired effects of the bioconjugation, and using 
catalysts which tolerate the different functions present on the protein. 
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Table 1. Ethyl diazoacetate insertion in N-H bonds of amino esters catalyzed by FeTSPPCl and 
RuTPPSCO in water.
a
 
 Catalyst Substrate
 
Time yield Mono/Bis 
ratio (%)
b 
1 ----------- R = Tryptophan  24 0 ------- 
2 TSPPFeCl Aniline 15 min 43 100:0 
3 TSPPFeCl R = Tryptophan  15 min 66 82:18 
4
c 
TSPPFeCl R= -CH2PhOH  15 min 71 86:14 
5 TSPPFeCl R= -CH2Ph  15 min 62 83 :17 
6 TSPPFeCl R= H  15 min 43 68:32 
7 TPPFeCl R = Tryptophan  2 min  82 90 :10 
8 TPPFeCl R= -CH2Ph 2 min 80 89:11 
      
9 TSPPFeCl Mono-inserted tryp. 24h traces  
      
10
d 
TSPPFeCl Mono-inserted tryp. 1h 48  
      
11
e 
TSPPRuCO R = Tryptophan  4h 56 80:20 
      
 
Reaction conditions : 
a
Catalyst/substrate/diazo mixture (1:100:100) in 1mL of CBS (pH 10) at 25°C. 
b
determined by 
1
H NMR. 
C
Solvent: EtOH/CBS (50/50) (pH 10). 
d
 20 equiv of sodium dithionite vs 
catalyst are added.
e 
Amino ester and diazo dissolved in ethanol are progressively added to a buffer 
solution (CBS pH 10) containing the catalyst. 
 
 
Table 2. Insertion of 4-(trifluoromethyl)benzyl diazoacetate (F) and  4-(thiomethyl)benzyl 
diazoacetate (S) in N-H bond of amino esters catalyzed by TPPFeCl in CH2Cl2. 
 Diazo Catalyst Substrate time Yield (%)
a 
1 F TPPFeCl Aniline  2 min 97  
2 F TPPFeCl Tryptophan      2 min 88  
3 F TPPFeCl Phenylalanine     2 min 87 
4 F TPPFeCl Tyrosine     2 min 66  
5 S TPPFeCl Aniline  2 min 62  
6 S TPPFeCl Tyrosine  2 min 50  
7 S TPPFeCl Tryptophan   2 min 67  
8 S TPPFeCl Phenylalanine 2 min 63 
 
Reaction conditions: a solution of substrate/diazo/TPPFeCl) mixture  (1 :1 :0.01) in 1 ml of CH2Cl2  placed under 
argon at 25°C was stirred for 2 min. 
Table 3. Insertion of 4-(trifluoromethyl)benzyl diazoacetate (F) and  4-(thiomethyl)benzyl 
diazoacetate (S) in N-H bond of aminoesters catalyzed by TPPSFeCl in water/methanol.  
 
 Diazo catalyst Amino ester time yield (%) 
1 F TPPSFeCl Tryptophan 10 min 79 
2 F TPPSFeCl Phenylalanine 10 min 81 
3 F TPPSFeCl Tyrosine 10 min 51 
4
a 
F TPPSRuCO Tryptophan 4 heures  45 
5 S TPPSFeCl Tyrosine 10 min 33 
6 S TPPSFeCl Tryptophan 10 min 51 
 
Reaction conditions: a solution of substrate/diazo/catalyst mixture (1 :1 :0.01) in 1 ml of MeOH/CBS pH 10)  
(1/1) placed under argon was stirred at 25°C. 
a 
lDiazo and amino ester  dissolved in MeOH were added to the 
buffer solution ((CBS pH 10) containing the catalyst and stirred for  4 h.    
 
Tabe 4. Insertion of diisopropyl diazomethylphosphonate in N-H bond of amino esters catalyzed by 
TSPPFeCl in water/methanol.  
 
 
Substrate Yield (%)
 
1 Tryptophan 90 
2 Tyrosine 92 
3 Phenylalanine 81 
4 Aniline 87 
5
a 
Aniline 96 
  
Reaction conditions: a solution of  substrate/diazo/catalyst mixture (1:1:0.01)  in 2 ml of (MeOH:CBS pH 10) 
(50:50)  was stirred at 25°C for 1 h. 
a
 solvent : CH2Cl2, catalyst : TPPFeCl  
 
 
 
Table 5. Alkylation of N-Terminus of Insulin by TSPPFeCl-Catalyzed Carbenoid Transfer Reactions. 
 
 Catalyst (conc.) Diazo
a
 Conversion 
(%) 
Mono/bis 
inserted ratio 
1 TSPPRuCO (0.17 mM) EDA (1 mM)  65 60 : 5 
2 TSPPRuCO (0.034 mM) EDA (0,25 mM) 14 99 : 1 
3
b 
TSPPFeCl (0.034 mM) EDA (0,25 mM) 90 90 : 10 
4
b 
TSPPFeCl (0.034 mM) S (0,25 mM) traces  
5
b 
TSPPFeCl (0.034 mM) F (0,25 mM) 75 98 : 2 
6
b 
TSPPFeCl (0.034 mM) DDMP (0,25 mM) traces  
7
b 
TSPPFeCl (0.17 mM) DDMP (0,25 mM)  20 100 : 0 
 
Reaction conditions: the solution of insulin, diazo and catalyst was stirred for 1h at 25°C in a PBS (pH 
7.4)/MeCN (7/3) mixture. aEDA = ethyl diazoacetate, F = 4-(trifluoromethyl)benzyl diazoacetate and S = 4-
(thiomethyl)benzyl diazoacetate, DDMP = diisopropyl diazomethylphosphonate.b one equiv of cobaltocene (vs 
catalyst) was added. 
 
 
 
 Fig. 1. Structure of the catalysts. 
 
 
Fig. 2. 
1
H-
13
C HMBC spectrum of ethyl diazoacetate insertion in N-H terminus bond of tryptophan. 
 
 
Fig. 3.  HPLC chromatograms of racemic (A) and optically active (B) phenylalanine N-H insertion with 
ethyl diazoacetate. 
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Fig. 4. MALDI-TOF of coupling ethyl diazoacetate (A) and 4-(trifluoromethyl)benzyl diazoacetate (B) 
to bovine insulin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Mass spectrum of insulin after ethyl diazoacetate coupling. 
L H Q N V F 
b5* b4* b3* a2*, b2* a1* 
  
Fig. 6. 1H NMR of insulin after A diazoacetate insertion and, B unmodified insulin. 
 
 
 
Scheme 1. Synthesis of benzyl diazoacetate derivatives. 
 
 
 
 
Scheme 2. Catalytic insertion of ethyl diazoacetate in N-H bond of amino esters. 
 
 
 
Scheme 3. Catalytic insertion of benzyl diazoacetate derivatives in N-H bond of amino esters. 
 
 
 
 
Scheme 4. Catalytic insertion of diisopropyl diazomethylphosphonate derivatives in N-H bond of 
amino esters. 
